Beta

Proposal:COVID–19 Medical Production Act

This proposal is archived and closed to further debate. It was introduced in the 117th Congress, which has concluded, and the bill was not enacted into law.
Bill HR 1720
Type of Legislation House Bill
Congress 117
Status Archived — 117th Congress concluded
Source View original on Congress.gov
Geographic Scope
National

Description

COVID-19 Medical Production Act

This bill provides additional funding for FY2021 to acquire medical supplies, vaccines, and other equipment to combat COVID-19 (i.e., coronavirus disease 2019) using authorities under the Defense Production Act of 1950. That act confers on the President a broad set of authorities to influence domestic industry to provide essential materials and goods for the national defense.

This funding is available through FY2025. Beginning in FY2023, it may be used to meet public health needs to address any pathogen determined by the President to have the potential to create a public health emergency.

Bill Title

COVID–19 Medical Production Act

Linked Goals

Steps

  • 2021-03-09: Referred to the House Committee on Financial Services.
  • 2021-03-09: Introduced in House
  • 2021-03-09: Introduced in House

Projected Outcome

A more informed proposal or public response aligned with the Promote General Welfare goal.

Retrieved from "https://beta.wikipraxis.org/index.php?title=Proposal:COVID–19_Medical_Production_Act&oldid=25823"